Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity

By Parra S.   Laurent F.   Subra G.   Deleuze-Masquefa C.   Benezech V.   Fabreguettes J.-R.   Vidal J.-P.   Pocock T.   Elliott K.   Small R.   Escale R.   Michel A.   Chapat J.-P.   Bonnet P.-A.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 3, 2001-03 ,pp. : 255-264

Elsevier

Access to resources Recommend Favorite

Effects of Theophylline on Lymphocyte Phosphodiesterase Activity - purification and properties of cyclic 3'5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine-3'5'-phosphate in human urine

By Tohda Y.   Nakahara H.   Kubo H.   Ohkawa K.   Fukuoka M.   Nakajima S.  

General Pharmacology, Vol. 31, Iss. 3, 1998-09 ,pp. : 409-413

Elsevier

Access to resources Recommend Favorite

Emerging drugs for sarcopenia: age-related muscle wasting

By Lynch Gordon S  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite

Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: characterization and the effects of E4021

By Miyahara M.   Ito M.   Itoh H.   Shiraishi T.   Isaka N.   Konishi T.   Nakano T.  

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 25-33

Elsevier

Access to resources Recommend Favorite

KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5

By Hirose R.   Okumura H.   Yoshimatsu A.   Irie J.   Onoda Y.   Nomoto Y.   Takai H.   Ohno T.   Ichimura M.  

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite